[Federal Register Volume 64, Number 46 (Wednesday, March 10, 1999)]
[Notices]
[Page 11923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5914]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Phase I Clinical Studies/Phase II Clinical Trials of New 
Chemopreventive Agents.
    Date: March 30, 1999.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Executive Plaza North, Conference Room F, 6130 Executive 
Boulevard, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Gerald G. Lovinger, Scientific Review 
Administrator, Grants Review Branch, Division of Extramural 
Activities, National Cancer Institute, National Institutes of 
Health, 6130 Executive Boulevard/EPN--Room 630D, Rockville, MD 
20892-7405, 301/496-7987.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398; Cancer Research Manpower, 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 3, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5914 Filed 3-9-99; 8:45 am]
BILLING CODE 4140-01-M